Revenue Recognition

3 Months Ended

Mar. 31, 2020

REVENUE RECOGNITION

Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2019.

We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.



Net Sales by Product Line
	Three Months
	2020		2019
Orthopaedics:
Knees	$	432	$	439
Hips	316		336
Trauma and Extremities	392		396
Other	82		79
	$	1,222	$	1,250
MedSurg:
Instruments	$	513	$	461
Endoscopy	455		470
Medical	587		531
Sustainability	67		65
	$	1,622	$	1,527
Neurotechnology and Spine:
Neurotechnology	$	483	$	469
Spine	261		270
	$	744	$	739
Total	$	3,588	$	3,516



Net Sales by Geography
	Three Months 2020				Three Months 2019
	United States		International		United States		International
Orthopaedics:
Knees	$	322	$	110	$	320	$	119
Hips	201		115		213		123
Trauma and Extremities	260		132		254		142
Other	69		13		63		16
	$	852	$	370	$	850	$	400
MedSurg:
Instruments	$	410	$	103	$	365	$	96
Endoscopy	364		91		376		94
Medical	454		133		416		115
Sustainability	66		1		64		1
	$	1,294	$	328	$	1,221	$	306
Neurotechnology and Spine:
Neurotechnology	$	301	$	182	$	300	$	169
Spine	196		65		208		62
	$	497	$	247	$	508	$	231
Total	$	2,643	$	945	$	2,579	$	937

Contract Assets and Liabilities

On March 31, 2020 there were no contract assets recorded on our Consolidated Balance Sheets.

Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $361 and $313 on March 31, 2020 and December 31, 2019.